The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and Technologies

Novel classes of molecules, such as engineered antibodies, antibiotic enhancers, siderophore conjugates, engineered phages, photo-switchable antibiotics, and genome editing facilitated by the CRISPR/Cas system, are providing new avenues to facilitate the development of antimicrobial therapies.

Article: MDPI